A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide

In this report, we would like to highlight the efficacy of bendamustine in a heavily pretreated patient, also refractory to pomalidomide. It is conceivable that different therapy combinations in heavily treated Multiple myeloma (MM) have to be explored, without “a priori” exclusion of ancient drugs,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerchione, Claudio, Nappi, Davide, Di Perna, Maria, Zacheo, Irene, Migliaccio, Ilaria, Salvatore, Dalila, Picardi, Marco, Pane, Fabrizio, Catalano, Lucio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378832/
https://www.ncbi.nlm.nih.gov/pubmed/28396778
http://dx.doi.org/10.1002/ccr3.773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378832/
https://www.ncbi.nlm.nih.gov/pubmed/28396778
http://dx.doi.org/10.1002/ccr3.773

Ejemplares similares